Holt Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Holt Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,007	Closed	-$208K	–	154
2023 Q1	$208K	Hold	3,007	–	–	0.04%	153
2022 Q4	$216K	Hold	3,007	–	–	0.04%	153
2022 Q3	$214K	Sell	3,007 -800	-21%	-$58K	0.06%	140
2022 Q2	$293K	Hold	3,807	–	–	0.06%	129
2022 Q1	$278K	Hold	3,807	–	–	0.05%	142
2021 Q4	$237K	Hold	3,807	–	–	0.04%	156
2021 Q3	$225K	Sell	3,807 -100	-3%	-$6.59K	0.04%	151
2021 Q2	$261K	Sell	3,907 -100	-2%	-$6.52K	0.05%	144
2021 Q1	$253K	Hold	4,007	–	–	0.05%	139
2020 Q4	$249K	Buy	+4,007	New	+$246K	0.06%	135
2016 Q2	–	Sell	-1,800	Closed	-$115K	–	138
2016 Q1	$115K	Buy	+1,800	New	+$114K	0.05%	139
2015 Q4	–	Sell	-1,800	Closed	-$107K	–	122
2015 Q3	$107K	Hold	1,800	–	–	0.04%	130
2015 Q2	$120K	Hold	1,800	–	–	0.05%	133
2015 Q1	$116K	Hold	1,800	–	–	0.05%	133
2014 Q4	$106K	Buy	+1,800	New	+$102K	0.05%	139
2014 Q3	–	Sell	-1,700	Closed	-$82K	–	118
2014 Q2	$82K	Hold	1,700	–	–	0.04%	129
2014 Q1	$88K	Hold	1,700	–	–	0.05%	114
2013 Q4	$90K	Buy	+1,700	New	+$86.6K	0.06%	108

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Holt Capital Partners's BMY Position: Q2 2023 in Review

Holt Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,007 shares — an estimated $208K sold.

Holt Capital Partners first reported a position in BMY in Q4 2013 and held it in 18 quarters. The position peaked at $293K in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Holt Capital Partners reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Holt Capital Partners sold 3,007 Bristol-Myers Squibb shares in Q2 2023, an estimated $208K.
Holt Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 18 quarters.
Holt Capital Partners's Bristol-Myers Squibb position peaked at $293K in Q2 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Holt Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.